Alterity Therapeutics Seeks ASX Quotation
Company Announcements

Alterity Therapeutics Seeks ASX Quotation

Alterity Therapeutics Ltd. (AU:ATH) has released an update.

Alterity Therapeutics Limited has announced the application for quotation of a total of 75,220,800 ordinary fully paid securities on the ASX under the code ATH, with the issue date set for July 18, 2024. This move is detailed in their latest Appendix 2A submission, marking a significant step for the company in the financial market.

For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.

Related Articles
GlobeNewswireAlterity Therapeutics to Present at MST Financial Webinar
TipRanks Australian Auto-Generated NewsdeskAlterity Therapeutics Unveils Future in Investor Webinar
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!